Peer- and community-led responses to HIV: A scoping review
In June 2021, United Nations (UN) Member States committed to ambitious targets for scaling up community-led responses by 2025 toward meeting the goals of ending the AIDS epidemic by 2030. These targets build on UN Member States 2016 commitments to ensure that 30% of HIV testing and treatment program...
Gespeichert in:
Veröffentlicht in: | PloS one 2021-12, Vol.16 (12), p.e0260555-e0260555 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0260555 |
---|---|
container_issue | 12 |
container_start_page | e0260555 |
container_title | PloS one |
container_volume | 16 |
creator | Ayala, George Sprague, Laurel van der Merwe, L Leigh-Ann Thomas, Ruth Morgan Chang, Judy Arreola, Sonya Davis, Sara L M Taslim, Aditia Mienies, Keith Nilo, Alessandra Mworeko, Lillian Hikuam, Felicita de Leon Moreno, Carlos Garcia Izazola-Licea, José Antonio |
description | In June 2021, United Nations (UN) Member States committed to ambitious targets for scaling up community-led responses by 2025 toward meeting the goals of ending the AIDS epidemic by 2030. These targets build on UN Member States 2016 commitments to ensure that 30% of HIV testing and treatment programmes are community-led by 2030. At its current pace, the world is not likely to meet these nor other global HIV targets, as evidenced by current epidemiologic trends. The COVID-19 pandemic threatens to further slow momentum made to date. The purpose of this paper is to review available evidence on the comparative advantages of community-led HIV responses that can better inform policy making towards getting the world back on track.
We conducted a scoping review to gather available evidence on peer- and community-led HIV responses. Using UNAIDS' definition of 'community-led' and following PRISMA guidelines, we searched peer-reviewed literature published from January 1982 through September 2020. We limited our search to articles reporting findings from randomized controlled trials as well as from quasi-experimental, prospective, pre/post-test evaluation, and cross-sectional study designs. The overall goals of this scoping review were to gather available evidence on community-led responses and their impact on HIV outcomes, and to identify key concepts that can be used to quickly inform policy, practice, and research.
Our initial search yielded 279 records. After screening for relevance and conducting cross-validation, 48 articles were selected. Most studies took place in the global south (n = 27) and a third (n = 17) involved youth. Sixty-five percent of articles (n = 31) described the comparative advantage of peer- and community-led direct services, e.g., prevention and education (n = 23) testing, care, and treatment programs (n = 8). We identified more than 40 beneficial outcomes linked to a range of peer- and community-led HIV activities. They include improved HIV-related knowledge, attitudes, intentions, self-efficacy, risk behaviours, risk appraisals, health literacy, adherence, and viral suppression. Ten studies reported improvements in HIV service access, quality, linkage, utilization, and retention resulting from peer- or community-led programs or initiatives. Three studies reported structural level changes, including positive influences on clinic wait times, treatment stockouts, service coverage, and exclusionary practices.
Findings from our scoping review u |
doi_str_mv | 10.1371/journal.pone.0260555 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2605185352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A684455677</galeid><doaj_id>oai_doaj_org_article_5754348447b9453e8623ce4ef4c25886</doaj_id><sourcerecordid>A684455677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-7e9d6c5686323c5228d57a1124eba0c0b9294c38d1032ade730b60169a02de063</originalsourceid><addsrcrecordid>eNqNkl1r1EAUhoMotlb_gWhAEL3IOt9JeiEsRe1CoeJHb4fJ5GR3liSznZlU---duGnZSC8kFwkzz3nPeU_eJHmJ0QLTHH_Y2sH1ql3sbA8LRATinD9KjnFJSSYIoo8Pvo-SZ95vEeK0EOJpckRZwQlC-Dg5_QrgslT1dapt1w29CbdZC3XqwEdlDz4NNj1fXZ2my9RruzP9Ot7dGPj1PHnSqNbDi-l9kvz8_OnH2Xl2cflldba8yLQoSchyKGuhuSgEJVRzQoqa5wpjwqBSSKOqJCXTtKgxokTVkFNUCYRFqRCpAQl6krze6-5a6-Vk28vRMS445SQSqz1RW7WVO2c65W6lVUb-PbBuLZULRrcgec5ZdM9YXpWMUyhEHAoYNEwTXhRjt49Tt6HqoNbQB6famej8pjcbubY3MtbG9Y7DvJsEnL0ewAfZGa-hbVUPdtjPLRAq6Ii--Qd92N1ErVU0YPrGxr56FJVLEZ1wLvI8UosHqPjU0BkdM9KYeD4reD8riEyA32GtBu_l6vu3_2cvr-bs2wN2A6oNG2_bIZgYpznI9qB21nsHzf2SMZJjxO-2IceIyynisezV4Q-6L7rLNP0DJZbyIg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2605185352</pqid></control><display><type>article</type><title>Peer- and community-led responses to HIV: A scoping review</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Ayala, George ; Sprague, Laurel ; van der Merwe, L Leigh-Ann ; Thomas, Ruth Morgan ; Chang, Judy ; Arreola, Sonya ; Davis, Sara L M ; Taslim, Aditia ; Mienies, Keith ; Nilo, Alessandra ; Mworeko, Lillian ; Hikuam, Felicita ; de Leon Moreno, Carlos Garcia ; Izazola-Licea, José Antonio</creator><contributor>Isaakidis, Petros</contributor><creatorcontrib>Ayala, George ; Sprague, Laurel ; van der Merwe, L Leigh-Ann ; Thomas, Ruth Morgan ; Chang, Judy ; Arreola, Sonya ; Davis, Sara L M ; Taslim, Aditia ; Mienies, Keith ; Nilo, Alessandra ; Mworeko, Lillian ; Hikuam, Felicita ; de Leon Moreno, Carlos Garcia ; Izazola-Licea, José Antonio ; Isaakidis, Petros</creatorcontrib><description>In June 2021, United Nations (UN) Member States committed to ambitious targets for scaling up community-led responses by 2025 toward meeting the goals of ending the AIDS epidemic by 2030. These targets build on UN Member States 2016 commitments to ensure that 30% of HIV testing and treatment programmes are community-led by 2030. At its current pace, the world is not likely to meet these nor other global HIV targets, as evidenced by current epidemiologic trends. The COVID-19 pandemic threatens to further slow momentum made to date. The purpose of this paper is to review available evidence on the comparative advantages of community-led HIV responses that can better inform policy making towards getting the world back on track.
We conducted a scoping review to gather available evidence on peer- and community-led HIV responses. Using UNAIDS' definition of 'community-led' and following PRISMA guidelines, we searched peer-reviewed literature published from January 1982 through September 2020. We limited our search to articles reporting findings from randomized controlled trials as well as from quasi-experimental, prospective, pre/post-test evaluation, and cross-sectional study designs. The overall goals of this scoping review were to gather available evidence on community-led responses and their impact on HIV outcomes, and to identify key concepts that can be used to quickly inform policy, practice, and research.
Our initial search yielded 279 records. After screening for relevance and conducting cross-validation, 48 articles were selected. Most studies took place in the global south (n = 27) and a third (n = 17) involved youth. Sixty-five percent of articles (n = 31) described the comparative advantage of peer- and community-led direct services, e.g., prevention and education (n = 23) testing, care, and treatment programs (n = 8). We identified more than 40 beneficial outcomes linked to a range of peer- and community-led HIV activities. They include improved HIV-related knowledge, attitudes, intentions, self-efficacy, risk behaviours, risk appraisals, health literacy, adherence, and viral suppression. Ten studies reported improvements in HIV service access, quality, linkage, utilization, and retention resulting from peer- or community-led programs or initiatives. Three studies reported structural level changes, including positive influences on clinic wait times, treatment stockouts, service coverage, and exclusionary practices.
Findings from our scoping review underscore the comparative advantage of peer- and community-led HIV responses. Specifically, the evidence from the published literature leads us to recommend, where possible, that prevention programs, especially those intended for people living with and disproportionately affected by HIV, be peer- and community-led. In addition, treatment services should strive to integrate specific peer- and community-led components informed by differentiated care models. Future research is needed and should focus on generating additional quantitative evidence on cost effectiveness and on the synergistic effects of bundling two or more peer- and community-led interventions.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0260555</identifier><identifier>PMID: 34852001</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; Antiretroviral drugs ; Appraisals ; Biology and Life Sciences ; Community health services ; Control ; Cost effectiveness ; COVID-19 ; Decision making ; Delivery of Health Care - organization & administration ; Delivery of Health Care - standards ; Epidemics ; Epidemiology ; Health Knowledge, Attitudes, Practice ; Health Literacy ; Health promotion ; Health risks ; HIV ; HIV infection ; HIV Infections - diagnosis ; HIV Infections - epidemiology ; HIV Infections - prevention & control ; Human immunodeficiency virus ; Humans ; Medication Adherence ; Medicine and Health Sciences ; Methods ; Pandemics ; Peer Group ; Prevention ; Public health ; Research and Analysis Methods ; Reviews ; Risk taking ; Self Efficacy ; Social aspects ; Synergistic effect ; United Nations</subject><ispartof>PloS one, 2021-12, Vol.16 (12), p.e0260555-e0260555</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Ayala et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Ayala et al 2021 Ayala et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-7e9d6c5686323c5228d57a1124eba0c0b9294c38d1032ade730b60169a02de063</citedby><cites>FETCH-LOGICAL-c692t-7e9d6c5686323c5228d57a1124eba0c0b9294c38d1032ade730b60169a02de063</cites><orcidid>0000-0003-3485-4760 ; 0000-0003-0914-3529 ; 0000-0002-3658-2570 ; 0000-0003-2255-7582 ; 0000-0003-4578-7217</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635382/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635382/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34852001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Isaakidis, Petros</contributor><creatorcontrib>Ayala, George</creatorcontrib><creatorcontrib>Sprague, Laurel</creatorcontrib><creatorcontrib>van der Merwe, L Leigh-Ann</creatorcontrib><creatorcontrib>Thomas, Ruth Morgan</creatorcontrib><creatorcontrib>Chang, Judy</creatorcontrib><creatorcontrib>Arreola, Sonya</creatorcontrib><creatorcontrib>Davis, Sara L M</creatorcontrib><creatorcontrib>Taslim, Aditia</creatorcontrib><creatorcontrib>Mienies, Keith</creatorcontrib><creatorcontrib>Nilo, Alessandra</creatorcontrib><creatorcontrib>Mworeko, Lillian</creatorcontrib><creatorcontrib>Hikuam, Felicita</creatorcontrib><creatorcontrib>de Leon Moreno, Carlos Garcia</creatorcontrib><creatorcontrib>Izazola-Licea, José Antonio</creatorcontrib><title>Peer- and community-led responses to HIV: A scoping review</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>In June 2021, United Nations (UN) Member States committed to ambitious targets for scaling up community-led responses by 2025 toward meeting the goals of ending the AIDS epidemic by 2030. These targets build on UN Member States 2016 commitments to ensure that 30% of HIV testing and treatment programmes are community-led by 2030. At its current pace, the world is not likely to meet these nor other global HIV targets, as evidenced by current epidemiologic trends. The COVID-19 pandemic threatens to further slow momentum made to date. The purpose of this paper is to review available evidence on the comparative advantages of community-led HIV responses that can better inform policy making towards getting the world back on track.
We conducted a scoping review to gather available evidence on peer- and community-led HIV responses. Using UNAIDS' definition of 'community-led' and following PRISMA guidelines, we searched peer-reviewed literature published from January 1982 through September 2020. We limited our search to articles reporting findings from randomized controlled trials as well as from quasi-experimental, prospective, pre/post-test evaluation, and cross-sectional study designs. The overall goals of this scoping review were to gather available evidence on community-led responses and their impact on HIV outcomes, and to identify key concepts that can be used to quickly inform policy, practice, and research.
Our initial search yielded 279 records. After screening for relevance and conducting cross-validation, 48 articles were selected. Most studies took place in the global south (n = 27) and a third (n = 17) involved youth. Sixty-five percent of articles (n = 31) described the comparative advantage of peer- and community-led direct services, e.g., prevention and education (n = 23) testing, care, and treatment programs (n = 8). We identified more than 40 beneficial outcomes linked to a range of peer- and community-led HIV activities. They include improved HIV-related knowledge, attitudes, intentions, self-efficacy, risk behaviours, risk appraisals, health literacy, adherence, and viral suppression. Ten studies reported improvements in HIV service access, quality, linkage, utilization, and retention resulting from peer- or community-led programs or initiatives. Three studies reported structural level changes, including positive influences on clinic wait times, treatment stockouts, service coverage, and exclusionary practices.
Findings from our scoping review underscore the comparative advantage of peer- and community-led HIV responses. Specifically, the evidence from the published literature leads us to recommend, where possible, that prevention programs, especially those intended for people living with and disproportionately affected by HIV, be peer- and community-led. In addition, treatment services should strive to integrate specific peer- and community-led components informed by differentiated care models. Future research is needed and should focus on generating additional quantitative evidence on cost effectiveness and on the synergistic effects of bundling two or more peer- and community-led interventions.</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Antiretroviral drugs</subject><subject>Appraisals</subject><subject>Biology and Life Sciences</subject><subject>Community health services</subject><subject>Control</subject><subject>Cost effectiveness</subject><subject>COVID-19</subject><subject>Decision making</subject><subject>Delivery of Health Care - organization & administration</subject><subject>Delivery of Health Care - standards</subject><subject>Epidemics</subject><subject>Epidemiology</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Health Literacy</subject><subject>Health promotion</subject><subject>Health risks</subject><subject>HIV</subject><subject>HIV infection</subject><subject>HIV Infections - diagnosis</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Infections - prevention & control</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Medication Adherence</subject><subject>Medicine and Health Sciences</subject><subject>Methods</subject><subject>Pandemics</subject><subject>Peer Group</subject><subject>Prevention</subject><subject>Public health</subject><subject>Research and Analysis Methods</subject><subject>Reviews</subject><subject>Risk taking</subject><subject>Self Efficacy</subject><subject>Social aspects</subject><subject>Synergistic effect</subject><subject>United Nations</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl1r1EAUhoMotlb_gWhAEL3IOt9JeiEsRe1CoeJHb4fJ5GR3liSznZlU---duGnZSC8kFwkzz3nPeU_eJHmJ0QLTHH_Y2sH1ql3sbA8LRATinD9KjnFJSSYIoo8Pvo-SZ95vEeK0EOJpckRZwQlC-Dg5_QrgslT1dapt1w29CbdZC3XqwEdlDz4NNj1fXZ2my9RruzP9Ot7dGPj1PHnSqNbDi-l9kvz8_OnH2Xl2cflldba8yLQoSchyKGuhuSgEJVRzQoqa5wpjwqBSSKOqJCXTtKgxokTVkFNUCYRFqRCpAQl6krze6-5a6-Vk28vRMS445SQSqz1RW7WVO2c65W6lVUb-PbBuLZULRrcgec5ZdM9YXpWMUyhEHAoYNEwTXhRjt49Tt6HqoNbQB6famej8pjcbubY3MtbG9Y7DvJsEnL0ewAfZGa-hbVUPdtjPLRAq6Ii--Qd92N1ErVU0YPrGxr56FJVLEZ1wLvI8UosHqPjU0BkdM9KYeD4reD8riEyA32GtBu_l6vu3_2cvr-bs2wN2A6oNG2_bIZgYpznI9qB21nsHzf2SMZJjxO-2IceIyynisezV4Q-6L7rLNP0DJZbyIg</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Ayala, George</creator><creator>Sprague, Laurel</creator><creator>van der Merwe, L Leigh-Ann</creator><creator>Thomas, Ruth Morgan</creator><creator>Chang, Judy</creator><creator>Arreola, Sonya</creator><creator>Davis, Sara L M</creator><creator>Taslim, Aditia</creator><creator>Mienies, Keith</creator><creator>Nilo, Alessandra</creator><creator>Mworeko, Lillian</creator><creator>Hikuam, Felicita</creator><creator>de Leon Moreno, Carlos Garcia</creator><creator>Izazola-Licea, José Antonio</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3485-4760</orcidid><orcidid>https://orcid.org/0000-0003-0914-3529</orcidid><orcidid>https://orcid.org/0000-0002-3658-2570</orcidid><orcidid>https://orcid.org/0000-0003-2255-7582</orcidid><orcidid>https://orcid.org/0000-0003-4578-7217</orcidid></search><sort><creationdate>20211201</creationdate><title>Peer- and community-led responses to HIV: A scoping review</title><author>Ayala, George ; Sprague, Laurel ; van der Merwe, L Leigh-Ann ; Thomas, Ruth Morgan ; Chang, Judy ; Arreola, Sonya ; Davis, Sara L M ; Taslim, Aditia ; Mienies, Keith ; Nilo, Alessandra ; Mworeko, Lillian ; Hikuam, Felicita ; de Leon Moreno, Carlos Garcia ; Izazola-Licea, José Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-7e9d6c5686323c5228d57a1124eba0c0b9294c38d1032ade730b60169a02de063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Antiretroviral drugs</topic><topic>Appraisals</topic><topic>Biology and Life Sciences</topic><topic>Community health services</topic><topic>Control</topic><topic>Cost effectiveness</topic><topic>COVID-19</topic><topic>Decision making</topic><topic>Delivery of Health Care - organization & administration</topic><topic>Delivery of Health Care - standards</topic><topic>Epidemics</topic><topic>Epidemiology</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Health Literacy</topic><topic>Health promotion</topic><topic>Health risks</topic><topic>HIV</topic><topic>HIV infection</topic><topic>HIV Infections - diagnosis</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Infections - prevention & control</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Medication Adherence</topic><topic>Medicine and Health Sciences</topic><topic>Methods</topic><topic>Pandemics</topic><topic>Peer Group</topic><topic>Prevention</topic><topic>Public health</topic><topic>Research and Analysis Methods</topic><topic>Reviews</topic><topic>Risk taking</topic><topic>Self Efficacy</topic><topic>Social aspects</topic><topic>Synergistic effect</topic><topic>United Nations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ayala, George</creatorcontrib><creatorcontrib>Sprague, Laurel</creatorcontrib><creatorcontrib>van der Merwe, L Leigh-Ann</creatorcontrib><creatorcontrib>Thomas, Ruth Morgan</creatorcontrib><creatorcontrib>Chang, Judy</creatorcontrib><creatorcontrib>Arreola, Sonya</creatorcontrib><creatorcontrib>Davis, Sara L M</creatorcontrib><creatorcontrib>Taslim, Aditia</creatorcontrib><creatorcontrib>Mienies, Keith</creatorcontrib><creatorcontrib>Nilo, Alessandra</creatorcontrib><creatorcontrib>Mworeko, Lillian</creatorcontrib><creatorcontrib>Hikuam, Felicita</creatorcontrib><creatorcontrib>de Leon Moreno, Carlos Garcia</creatorcontrib><creatorcontrib>Izazola-Licea, José Antonio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ayala, George</au><au>Sprague, Laurel</au><au>van der Merwe, L Leigh-Ann</au><au>Thomas, Ruth Morgan</au><au>Chang, Judy</au><au>Arreola, Sonya</au><au>Davis, Sara L M</au><au>Taslim, Aditia</au><au>Mienies, Keith</au><au>Nilo, Alessandra</au><au>Mworeko, Lillian</au><au>Hikuam, Felicita</au><au>de Leon Moreno, Carlos Garcia</au><au>Izazola-Licea, José Antonio</au><au>Isaakidis, Petros</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peer- and community-led responses to HIV: A scoping review</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>16</volume><issue>12</issue><spage>e0260555</spage><epage>e0260555</epage><pages>e0260555-e0260555</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>In June 2021, United Nations (UN) Member States committed to ambitious targets for scaling up community-led responses by 2025 toward meeting the goals of ending the AIDS epidemic by 2030. These targets build on UN Member States 2016 commitments to ensure that 30% of HIV testing and treatment programmes are community-led by 2030. At its current pace, the world is not likely to meet these nor other global HIV targets, as evidenced by current epidemiologic trends. The COVID-19 pandemic threatens to further slow momentum made to date. The purpose of this paper is to review available evidence on the comparative advantages of community-led HIV responses that can better inform policy making towards getting the world back on track.
We conducted a scoping review to gather available evidence on peer- and community-led HIV responses. Using UNAIDS' definition of 'community-led' and following PRISMA guidelines, we searched peer-reviewed literature published from January 1982 through September 2020. We limited our search to articles reporting findings from randomized controlled trials as well as from quasi-experimental, prospective, pre/post-test evaluation, and cross-sectional study designs. The overall goals of this scoping review were to gather available evidence on community-led responses and their impact on HIV outcomes, and to identify key concepts that can be used to quickly inform policy, practice, and research.
Our initial search yielded 279 records. After screening for relevance and conducting cross-validation, 48 articles were selected. Most studies took place in the global south (n = 27) and a third (n = 17) involved youth. Sixty-five percent of articles (n = 31) described the comparative advantage of peer- and community-led direct services, e.g., prevention and education (n = 23) testing, care, and treatment programs (n = 8). We identified more than 40 beneficial outcomes linked to a range of peer- and community-led HIV activities. They include improved HIV-related knowledge, attitudes, intentions, self-efficacy, risk behaviours, risk appraisals, health literacy, adherence, and viral suppression. Ten studies reported improvements in HIV service access, quality, linkage, utilization, and retention resulting from peer- or community-led programs or initiatives. Three studies reported structural level changes, including positive influences on clinic wait times, treatment stockouts, service coverage, and exclusionary practices.
Findings from our scoping review underscore the comparative advantage of peer- and community-led HIV responses. Specifically, the evidence from the published literature leads us to recommend, where possible, that prevention programs, especially those intended for people living with and disproportionately affected by HIV, be peer- and community-led. In addition, treatment services should strive to integrate specific peer- and community-led components informed by differentiated care models. Future research is needed and should focus on generating additional quantitative evidence on cost effectiveness and on the synergistic effects of bundling two or more peer- and community-led interventions.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>34852001</pmid><doi>10.1371/journal.pone.0260555</doi><tpages>e0260555</tpages><orcidid>https://orcid.org/0000-0003-3485-4760</orcidid><orcidid>https://orcid.org/0000-0003-0914-3529</orcidid><orcidid>https://orcid.org/0000-0002-3658-2570</orcidid><orcidid>https://orcid.org/0000-0003-2255-7582</orcidid><orcidid>https://orcid.org/0000-0003-4578-7217</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2021-12, Vol.16 (12), p.e0260555-e0260555 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2605185352 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Acquired immune deficiency syndrome AIDS Antiretroviral drugs Appraisals Biology and Life Sciences Community health services Control Cost effectiveness COVID-19 Decision making Delivery of Health Care - organization & administration Delivery of Health Care - standards Epidemics Epidemiology Health Knowledge, Attitudes, Practice Health Literacy Health promotion Health risks HIV HIV infection HIV Infections - diagnosis HIV Infections - epidemiology HIV Infections - prevention & control Human immunodeficiency virus Humans Medication Adherence Medicine and Health Sciences Methods Pandemics Peer Group Prevention Public health Research and Analysis Methods Reviews Risk taking Self Efficacy Social aspects Synergistic effect United Nations |
title | Peer- and community-led responses to HIV: A scoping review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T06%3A03%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peer-%20and%20community-led%20responses%20to%20HIV:%20A%20scoping%20review&rft.jtitle=PloS%20one&rft.au=Ayala,%20George&rft.date=2021-12-01&rft.volume=16&rft.issue=12&rft.spage=e0260555&rft.epage=e0260555&rft.pages=e0260555-e0260555&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0260555&rft_dat=%3Cgale_plos_%3EA684455677%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2605185352&rft_id=info:pmid/34852001&rft_galeid=A684455677&rft_doaj_id=oai_doaj_org_article_5754348447b9453e8623ce4ef4c25886&rfr_iscdi=true |